Pulmatrix Inc. logo — Changing medicine with a new generation of pulmonary-deliver...

Pulmatrix Inc.

Changing medicine with a new generation of pulmonary-delivered therapeutics

Founded 2003 United States Bedford, United States 18 employees Post-IPO Equity Biotechnology, Health and Wellness +1

General Information

Company Name Pulmatrix Inc.
Founded Year 2003
Location United States Bedford, United States
Founders / Decision Makers
Team member
Employees 18
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Pulmatrix Inc.. To contact Pulmatrix Inc., visit pulmatrix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Pulmatrix Inc. compare?

A PDF of Pulmatrix Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Pulmatrix Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Pulmatrix Inc.

**Pulmatrix Inc.** is dedicated to revolutionizing medicine through the development and commercialization of innovative therapeutics globally. With the proprietary iSPERSE™ technology, the company aims to optimize the delivery of respiratory and non-respiratory therapies through the respiratory system. Founded in **2003**, Pulmatrix operates within the **Biotechnology, Health and Wellness, and Pharmaceutical** industries. The latest milestone for the company was a **Post-IPO Equity investment** on **17 December 2021**. The specific investors in this round were not disclosed. Pulmatrix's slogan, "Changing medicine with a new generation of pulmonary-delivered therapeutics," encapsulates its commitment to pioneering medical advancements through advanced delivery mechanisms.

Business keywords: Biopharmaceuticals, Inhaled Therapies, Pulmonary Medicine, Clinical-stage Development, iSPERSE Technology, Drug Delivery Platform, Respiratory Diseases, Non-respiratory Therapies, ABPA Treatment, Lung Cancer Therapies, Patented Technology, Medical Innovation, Therapeutic Delivery, Patient Outcomes, Clinical Trials

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity Undisclosed -
17 Dec 2021
Post IPO Equity Undisclosed -
11 Feb 2021
Post IPO Equity Undisclosed -
08 Apr 2019
Grant Undisclosed -
01 Oct 2015
Post IPO Equity Undisclosed -
16 Jun 2015
Debt Financing Undisclosed -
25 Feb 2013
Series B Undisclosed -
15 Aug 2011
Grant Undisclosed -
14 Dec 2010
Series B Undisclosed -
02 Nov 2009
Series A Undisclosed -
11 Mar 2009

Pulmatrix Inc. Alternatives & Competitors

View All Alternatives
Pulmatrix Inc. vs

Since 1906 our mission is innovating Cure & Care to make patients’ lives better.

Series A
2468 employees
Biotechnology, Health Care
Pulmatrix Inc. vs

RNA Therapeutics New Drug Development Company

Series B
15 employees
Biotechnology, Pharmaceutical
Pulmatrix Inc. vs

A clinical stage oncology company developing personalised medicine approaches to cancer; cellular &...

Post-IPO Equity
14 employees
Biopharma, Biotechnology

FAQ About Pulmatrix Inc.

Changing medicine with a new generation of pulmonary-delivered therapeutics
Pulmatrix Inc. was founded in 2003.
Pulmatrix Inc. is headquartered in Bedford, United States.
Pulmatrix Inc. operates in Biotechnology, Health and Wellness and Pharmaceutical. Its work centres on Biopharmaceuticals, Inhaled Therapies, Pulmonary Medicine and Clinical-stage Development.
Pulmatrix Inc. has approximately 18 employees.
Pulmatrix Inc. has completed 10 funding rounds. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Pulmatrix Inc. include Breath Therapeutics, Autotelic Bio Inc., Prescient Therapeutics, PhaseBio Pharmaceuticals, Inc., Avalyn Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pulmatrix Inc. and Breath Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pulmatrix Inc., https://bouncewatch.com/company/pulmatrix-inc, updated 4 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes